1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Esophagitis Global Clinical Trials Review, H1, 2015

Esophagitis Global Clinical Trials Review, H1, 2015

  • April 2015
  • -
  • Global Data
  • -
  • 106 pages

Esophagitis Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, “Esophagitis Global Clinical Trials Review, H1, 2015" provides data on the Esophagitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Esophagitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Esophagitis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Esophagitis Global Clinical Trials Review, H1, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Esophagitis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Esophagitis to Gastrointestinal Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Esophagitis to Gastrointestinal Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Esophagitis 25
Subjects Recruited Over a Period of Time 30
Clinical Trials by Sponsor Type 31
Prominent Sponsors 32
Top Companies Participating in Esophagitis Therapeutics Clinical Trials 33
Prominent Drugs 35
Clinical Trial Profiles 36
Clinical Trial Overview of Top Companies 36
AstraZeneca PLC 36
Clinical Trial Overview of AstraZeneca PLC 36
Takeda Pharmaceutical Company Limited 44
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 44
Eisai Co., Ltd. 50
Clinical Trial Overview of Eisai Co., Ltd. 50
Johnson and Johnson 53
Clinical Trial Overview of Johnson and Johnson 53
Pfizer Inc. 55
Clinical Trial Overview of Pfizer Inc. 55
Indivior PLC 57
Clinical Trial Overview of Indivior PLC 57
Novartis AG 59
Clinical Trial Overview of Novartis AG 59
Shire Plc 60
Clinical Trial Overview of Shire Plc 60
Yuhan Corporation 61
Clinical Trial Overview of Yuhan Corporation 61
Dr. Reddy's Laboratories Limited 62
Clinical Trial Overview of Dr. Reddy's Laboratories Limited 62
Clinical Trial Overview of Top Institutes / Government 63
Mayo Clinic 63
Clinical Trial Overview of Mayo Clinic 63
Shimane University 64
Clinical Trial Overview of Shimane University 64
Academic Medical Center 65
Clinical Trial Overview of Academic Medical Center 65
The University of Utah 66
Clinical Trial Overview of The University of Utah 66
Cincinnati Children's Hospital Medical Center 67
Clinical Trial Overview of Cincinnati Children's Hospital Medical Center 67
Juntendo University School of Medicine 68
Clinical Trial Overview of Juntendo University School of Medicine 68
Osaka City University 69
Clinical Trial Overview of Osaka City University 69
Seoul National University Hospital 70
Clinical Trial Overview of Seoul National University Hospital 70
University of North Carolina 71
Clinical Trial Overview of University of North Carolina 71
Yokohama City University 72
Clinical Trial Overview of Yokohama City University 72
Five Key Clinical Profiles 73
Appendix 104
Abbreviations 104
Definitions 104
Research Methodology 105
Secondary Research 105
About GlobalData 106
Contact Us 106
Disclaimer 106
Source 106

List of Tables
Esophagitis Therapeutics, Global, Clinical Trials by Region, 2015* 7
Esophagitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Esophagitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Esophagitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Esophagitis Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Esophagitis Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Esophagitis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Esophagitis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 14
Proportion of Esophagitis to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 15
Esophagitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Esophagitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Esophagitis to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 18
Esophagitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Esophagitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Esophagitis Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Esophagitis Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Esophagitis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Esophagitis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Esophagitis Therapeutics, Global, Suspended Clinical Trials, 2015* 25
Esophagitis Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26
Esophagitis Therapeutics, Global, Terminated Clinical Trials, 2015* 27
Esophagitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 30
Esophagitis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 31
Esophagitis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 32
Esophagitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 34
Esophagitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 35
Esophagitis Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2015* 36
Esophagitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2015* 44
Esophagitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2015* 50
Esophagitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson and Johnson, 2015* 53
Esophagitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 55
Esophagitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Indivior PLC, 2015* 57
Esophagitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 59
Esophagitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Shire Plc, 2015* 60
Esophagitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Yuhan Corporation, 2015* 61
Esophagitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Dr. Reddy's Laboratories Limited, 2015* 62
Esophagitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2015* 63
Esophagitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Shimane University, 2015* 64
Esophagitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Center, 2015* 65
Esophagitis Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Utah, 2015* 66
Esophagitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Cincinnati Children's Hospital Medical Center, 2015* 67
Esophagitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Juntendo University School of Medicine, 2015* 68
Esophagitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Osaka City University, 2015* 69
Esophagitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2015* 70
Esophagitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of North Carolina, 2015* 71
Esophagitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Yokohama City University, 2015* 72

List of Figures
Esophagitis Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Esophagitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Esophagitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Esophagitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Esophagitis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Esophagitis Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Esophagitis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Esophagitis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015* 14
Proportion of Esophagitis to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 15
Esophagitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Esophagitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Esophagitis to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 18
Esophagitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Esophagitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Esophagitis Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Esophagitis Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Esophagitis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Esophagitis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Esophagitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 30
Esophagitis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 31
Esophagitis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 32
Esophagitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 33
Esophagitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 35
GlobalData Methodology 105

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.